Yield10 Bioscience IncOTCQB:YTEN
- LAST PRICE0.5250
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.3001/ 25
- Ask / Lots0.5000/ 25
- Open / Previous Close--- / 0.5250
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | YTEN |
|---|---|---|
| 10:02 ET | 563 | 0.65 |
| 10:06 ET | 1000 | 0.64 |
| 10:08 ET | 1000 | 0.65 |
| 10:45 ET | 284 | 0.4006 |
| 03:57 ET | 8000 | 0.525 |
Nov 8, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Yield10 Bioscience Inc | 363.7K | 0.0x | --- |
Sangui BioTech International Inc | 314.9K | -2.5x | --- |
Navidea Biopharmaceuticals Inc | 100.1K | 0.0x | --- |
GlobeStar Therapeutics Corp | 348.9K | -0.1x | --- |
Neximmune Inc | 338.7K | 0.0x | --- |
LadRx Corp | 365.0K | -0.1x | --- |
Company Information
Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa (Camelina) as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and PHA bioplastics for use as biodegradable bioplastics. The Company is pursuing Camelina seed oil products for two market opportunities and value chains. The first product is seed oil produced by Camelina, which is genetically engineered to enable production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). The second product is Camelina seed oil for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD) and sustainable aviation fuel (SAF).
Contact Information
- Headquarters
- 19 Presidential WayWOBURN, MA, United States 01801
- Phone
- 617-583-1700
- Fax
- 302-655-5049
Executives
- Non-Executive Independent Chairman of the Board
- Robert Van Nostrand
- President, Chief Executive Officer, Director
- Oliver Peoples
- Chief Accounting Officer, Vice President - Finance, Treasurer
- Charles Haaser
- Vice President - Planning and Corporate Communications, Secretary
- Lynne Brum
- Independent Director
- Sherri Brown
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $363.7K |
|---|---|
Revenue (TTM) | $750.0K |
Shares Outstanding | 692.7K |
Yield10 Bioscience Inc does not pay a dividend. | |
Beta | 1.51 |
EPS | $-135.92 |
Book Value | $-4.95 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,679.07% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
